ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639521 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639521; 2) Community: the network communities that were significantly associated with the response to NSC 639521; 3) Molecule: the relationships between components within communities and NSC 639521; 4) MDR: the compounds that were significantly associated with the NSC 639521.

NSC Compound Enrichment Correlation
NSC 722779 dabequine 0.00189155427362374 0.26436456
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00189155427362374 0.62278614
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.00189155427362374 0.44081473
NSC 731155 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt 0.00189155427362374 0.46995161
NSC 745451 Null 0.00189155427362374 0.65565182
NSC 754241 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.00189155427362374 0.48205827
NSC 90137 Benzene, 1-[(2,4-dinitrophenyl)thio]-4-methyl-2-nitro- 0.00189155427362374 0.57280939
NSC 106486 Formycin B 0.0019895000709106 0.073235284
NSC 140873 2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide 0.0019895000709106 0.56742148
NSC 335753 HELIANGOLIDE 0.0019895000709106 0.45029808
Total:136  Current:20    [First] [Prev] [Next] [Last]